Open access · CC-BY
via OpenAlex
Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease
Tommi P. Kilpeläinen, Ulrika H. Julku, Reinis Svarcbahs, Timo T. Myöhänen
Scientific Reports · 2019 · ▲ 46 citations
Abstract
Alpha-synuclein (aSyn) is the main component of Lewy bodies, the histopathological marker in Parkinson's disease (PD), and point mutations and multiplications of the aSyn coding SNCA gene correlate with early onset PD. Therefore, various transgenic mouse models overexpressing native or point-mutated aSyn have been developed. Although these models show highly increased aSyn expression they rarely capture dopaminergic cell loss and show a behavioural phenotype only at old age, whereas SNCA mutations are risk factors for PD with earlier onset. The aim of our study was to re-characterize a transgenic mouse strain carrying both A30P and A53T mutated human aSyn. Our study revealed decreased locomotor activity for homozygous transgenic mice starting from 3 months of age which was different from previous studies with this mouse strain that had behavioural deficits starting only after 7-9 months. Additionally, we found a decreased amphetamine response in locomotor activity and decreased extracellular dopaminergic markers in the striatum and substantia nigra with significantly elevated levels of aSyn oligomers. In conclusion, homozygous transgenic A30P*A53T aSyn mice capture several phenotypes of PD with early onset and could be a useful tool for aSyn studies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-019-54034-z
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Kilpeläinen, T.P., Julku, U.H., Svarcbahs, R., & Myöhänen, T.T. (2019). Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-019-54034-z
Vancouver
Kilpeläinen TP, Julku UH, Svarcbahs R, Myöhänen TT. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease. Scientific Reports. 2019. doi:10.1038/s41598-019-54034-z.
BibTeX
@article{tommi2019Behavi,
title = {Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease},
author = {Tommi P. Kilpeläinen and Ulrika H. Julku and Reinis Svarcbahs and Timo T. Myöhänen},
journal = {Scientific Reports},
year = {2019},
doi = {10.1038/s41598-019-54034-z},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2021
Open access · OA
The Use of a Novel Alpha-Synuclein Binding Aptamer in Models of Parkinson’s Disease
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY
Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinson’s Disease
Brain 2023
Open access · CC-BY
Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Movement Disorders 2010
Preprint · OA
Staging of α‐synuclein in the olfactory bulb in a model of Parkinson's disease: Cell types involved
Neurobiology of Aging 2007
Preprint · OA
Synuclein activates microglia in a model of Parkinson's disease
Frontiers in Molecular Neuroscience 2022
Open access · CC-BY